Project Grant G11AI183317
Award Date
8/22/24
Completion Date
1/31/26
Dollars Obligated
$108K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Argentina
Similar Awards
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
This Project Grant award of $245,178, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Aga Khan University, aims to transform the university's research administration infrastructure and build research administration capacity. The key objectives are to: (1) develop a strategic plan for improving research administration and financial management, especially for U.S. federal-funded projects; (2) deliver tailored...
This Project Grant award of $1,454,386.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports fundamental research to better understand the epigenetic regulation of the HIV-1 viral RNA cap. The research aims to define the structural basis of HIV cap hypermethylation and its linkage to modulating host innate immune signaling, with the goal of developing new treatments to neutralize deleterious...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA Program 93.855 - Allergy and Infectious Diseases Research, provides $209,164 to Colorado State University to recruit, train, and retain outstanding clinician researchers focused on translational research in infectious disease, immunologic, and allergic diseases. The overarching goal is to develop veterinary scientists who will contribute to biomedical research addressing pressing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $340,452 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Puerto Rico Comprehensive Cancer Center. The grant, titled "Research Education Program on Microbes, Infections, and Cancer (REPMIC)", will recruit and train 50 post-baccalaureate individuals over 5 years to participate in a 9-month mentored research program focused on understanding the...
This federal Project Grant award of $643,718 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how interferon-regulatory factors (IRFs) and STAT transcription factors remodel the epigenome and chromosome organization of macrophages to reprogram their immune responses. The research aims to: 1) dissect the roles of innate immune IRFs in de novo enhancer formation, 2)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 to support research on the role of antibodies in controlling virus infections through Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The research aims to elucidate the...
This $198,630 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to characterize porin mutations and expand the capabilities of the BADLOCK CRISPR-based diagnostic test. The goal is to improve diagnostic capacity for antibiotic-resistant bacterial infections, especially carbapenem-resistant Enterobacterales, in resource-limited settings. Key activities include...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $812,603 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Houston System. The grant aims to develop selective calcium-dependent protein kinase 1 (CDPK1) inhibitors that can efficiently access the gastrointestinal system to treat cryptosporidiosis, a significant public health threat with limited treatment options. The research will focus on structure-activity...
This Project Grant award of $1,211,704.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund comprehensive studies to elucidate the pathogenesis of severe dengue disease during primary infections. The research aims to determine differences in innate, antibody, and T-cell immune responses between severe primary and secondary dengue infections. The grant will leverage state-of-the-art tools and...